Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer-Reference-Cited by-同舟云学术

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer

Published:2009-03 Issue:3 Volume:20 Page:475-480
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Enzinger P.C.,Ryan D.P.,Clark J.W.,Muzikansky A.,Earle C.C.,Kulke M.H.,Meyerhardt J.A.,Blaszkowsky L.S.,Zhu A.X.,Fidias P.,Vincitore M.M.,Mayer R.J.,Fuchs C.S.

Funder

Pfizer Oncology

Sanofi-Aventis

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/3/475/458268/mdn658.pdf

Reference22 articles.

1. Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients;Dank;J Clin Oncol,2005

2. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group;Van Cutsem;J Clin Oncol,2006

3. Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): efficacy and safety results;Kang;J Clin Oncol,2006

4. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer;Ilson;J Clin Oncol,1999

5. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study;Ajani;Cancer,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-02

2. Cancer of the Esophagus;Abeloff's Clinical Oncology;2020

3. Gastric Adenocarcinoma;The American Cancer Society's Oncology in Practice;2018-02-16

4. Systemic therapy for esophageal cancer: chemotherapy;Chinese Clinical Oncology;2017-10

5. Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer;Cancer Research and Treatment;2017-04-15